GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Cash from Discontinued Operating Activities

HURA (TuHURA Biosciences) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

TuHURA Biosciences's Cash from Discontinued Operating Activities for the three months ended in Mar. 2025 was $0.00 Mil. It means TuHURA Biosciences received $0.00 Mil from discontinued investing activities. TuHURA Biosciences's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

TuHURA Biosciences Cash from Discontinued Operating Activities Historical Data

The historical data trend for TuHURA Biosciences's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Cash from Discontinued Operating Activities Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash from Discontinued Operating Activities
- - - -

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TuHURA Biosciences Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

TuHURA Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
SEER LYEL ALEC NKTX ENTA EXOZ IFRX NKTR TARA VTYX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
PL3:Germany
Address
10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
Website
https://www.tuhurabio.com
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.